Enzymatic activity of endogenous telomerase associated with intact nuclei from human leukemia CEM cells.

Telomerase, a telomere-specific DNA polymerase and novel target for chemotherapeutic intervention, is found in many types of cancers. Telomerase activity is typically assayed using an exogenous primer and cellular extracts as the source of enzyme. Since the nuclear organization might affect telomerase function, we developed a system in which telomerase in intact nuclei catalyzes primer extension. Telomerase activity in isotonically isolated nuclei from human CEM cells shows low processivity (addition of up to four TTAGGG repeats). In contrast, telomerase activity which leaks into a 500 g postnuclear supernatant and the activity in a CHAPS extract are highly processive. The nucleotide inhibitor, 7-deaza-dGTP, seems to be more inhibitory against the nuclei-associated enzyme compared to telomerase from cytoplasmic extracts. However, 7-deaza-dATP and ddGTP are less inhibitory against nuclei-associated telomerase. The results suggest that the association of telomerase with the nuclear chromatin affects telomerase activity. Examination of telomerase activity in a more natural nuclear environment may shed new light on the telomerase function and provide a useful system for the evaluation of new telomerase inhibitors.

[1]  H. Biessmann,et al.  Telomeric repeat sequences , 1994, Chromosoma.

[2]  T. Cech,et al.  Telomerase and the maintenance of chromosome ends. , 1999, Current opinion in cell biology.

[3]  C. Greider.  Telomeres Do D-Loop–T-Loop , 1999, Cell.

[4]  J. Griffith,et al.  Mammalian Telomeres End in a Large Duplex Loop , 1999, Cell.

[5]  Pitts,et al.  The telomerase challenge - an unusual problem in drug discovery. , 1999, Drug discovery today.

[6]  C. Price.  Telomeres and telomerase: broad effects on cell growth. , 1999, Current opinion in genetics & development.

[7]  D. V. Von Hoff,et al.  Regulation of catalytic activity and processivity of human telomerase. , 1999, Biochemistry.

[8]  Y. Cong,et al.  The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter. , 1999, Human molecular genetics.

[9]  M. Kukhanova,et al.  Telomerase from human leukemia cells: properties and its interaction with deoxynucleoside analogues. , 1998, Cancer research.

[10]  L. Hurley,et al.  Effect of DNA secondary structure on human telomerase activity. , 1998, Biochemistry.

[11]  R. Wheelhouse,et al.  Cationic Porphyrins as Telomerase Inhibitors: the Interaction of Tetra-(N-methyl-4-pyridyl)porphine with Quadruplex DNA , 1998 .

[12]  M. Bass,et al.  Human telomerase contains evolutionarily conserved catalytic and structural subunits. , 1997, Genes & development.

[13]  J. Shay,et al.  Normal human chromosomes have long G-rich telomeric overhangs at one end. , 1997, Genes & development.

[14]  S. Neidle,et al.  Inhibition of human telomerase by a G-quadruplex-interactive compound. , 1997, Journal of medicinal chemistry.

[15]  Lea Harrington,et al.  A Mammalian Telomerase-Associated Protein , 1997, Science.

[16]  M. Salazar,et al.  Human telomerase inhibition by 7-deaza-2'-deoxypurine nucleoside triphosphates. , 1996, Biochemistry.

[17]  Parkinson Ek.  Do telomerase antagonists represent a novel anti-cancer strategy? , 1996 .

[18]  V A Zakian,et al.  Telomeres: Beginning to Understand the End , 1995, Science.

[19]  A. Jeffreys,et al.  Mechanisms underlying telomere repeat turnover, revealed by hypervariable variant repeat distribution patterns in the human Xp/Yp telomere. , 1995, The EMBO journal.

[20]  E. Rogaev,et al.  Telomere shortening is associated with cell division in vitro and in vivo. , 1995, Experimental cell research.

[21]  M. S. Rhyu.  Telomeres, telomerase, and immortality. , 1995, Journal of the National Cancer Institute.

[22]  R. Kobayashi,et al.  Purification of tetrahymena telomerase and cloning of genes encoding the two protein components of the enzyme , 1995, Cell.

[23]  J. Crittenden,et al.  Gel Shift and UV Cross-linking Analysis of Tetrahymena Telomerase (*) , 1995, The Journal of Biological Chemistry.

[24]  C B Harley,et al.  Telomeres and telomerase in aging and cancer. , 1995, Current opinion in genetics & development.

[25]  Healy Kc.  Telomere dynamics and telomerase activation in tumor progression: prospects for prognosis and therapy. , 1995, Oncology research.

[26]  C. Harley,et al.  Telomerase, cell immortality, and cancer. , 1994, Cold Spring Harbor symposia on quantitative biology.

[27]  D. Shippen.  Telomeres and telomerases. , 1993, Current opinion in genetics & development.

[28]  J. Day,et al.  Telomeres and their possible role in chromosome stabilization , 1993, Environmental and molecular mutagenesis.

[29]  C B Harley,et al.  Telomere end-replication problem and cell aging. , 1992, Journal of molecular biology.

[30]  T. Lange.  Human telomeres are attached to the nuclear matrix. , 1992 .

[31]  P. Walker,et al.  Periodicity of DNA folding in higher order chromatin structures. , 1990, The EMBO journal.

[32]  L. Szmigiero,et al.  Induction of DNA-protein crosslinks by antitumor 1-nitro-9-aminoacridines in L1210 leukemia cells. , 1989, Biochemical pharmacology.

[33]  P. Walker,et al.  Chromatin structure. Evidence that the 30-nm fiber is a helical coil with 12 nucleosomes/turn. , 1987, The Journal of biological chemistry.

[34]  P. Walker,et al.  Chromatin structure. Further evidence against the existence of a beaded subunit for the 30-nm fiber. , 1987, Journal of Biological Chemistry.

[35]  D. Jackson,et al.  Different populations of DNA polymerase α in HeLa cells , 1986 .